The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
tert-Butyl 4-[(2-{[6-(3-methyl-1,2,4-oxadiazol-5-yl)-1H-benzimidazol-2-yl]amino}pyridin-4-yl)methyl]piperazine-1-carboxylate ID: ALA4545291
PubChem CID: 129245450
Max Phase: Preclinical
Molecular Formula: C25H30N8O3
Molecular Weight: 490.57
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)OC(C)(C)C)CC5)ccn4)[nH]c3c2)n1
Standard InChI: InChI=1S/C25H30N8O3/c1-16-27-22(36-31-16)18-5-6-19-20(14-18)29-23(28-19)30-21-13-17(7-8-26-21)15-32-9-11-33(12-10-32)24(34)35-25(2,3)4/h5-8,13-14H,9-12,15H2,1-4H3,(H2,26,28,29,30)
Standard InChI Key: YFHGVXAURSKWLJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
6.5898 -17.0991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5886 -17.9227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3008 -18.3358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0146 -17.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0118 -17.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2990 -16.6902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8778 -16.6906 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1661 -17.0994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4159 -16.7628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0814 -17.9118 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2780 -18.0821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8699 -17.3705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0510 -17.3713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6392 -18.0828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0564 -18.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8740 -18.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7220 -16.6842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4354 -17.0901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4359 -17.9132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1411 -18.3232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8538 -17.9113 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8527 -17.0890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1388 -16.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6493 -19.5124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8329 -19.6018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6669 -20.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3808 -20.8154 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9894 -20.2615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9179 -20.7463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5656 -18.3240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5656 -19.1453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2775 -17.9113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9893 -18.3240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7011 -17.9113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9893 -19.1453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6983 -18.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 8 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 1 0
17 18 1 0
18 19 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 24 1 0
15 24 1 0
26 29 1 0
21 30 1 0
30 31 2 0
30 32 1 0
32 33 1 0
33 34 1 0
33 35 1 0
33 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 490.57Molecular Weight (Monoisotopic): 490.2441AlogP: 4.11#Rotatable Bonds: 5Polar Surface Area: 125.30Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.14CX Basic pKa: 6.17CX LogP: 3.66CX LogD: 3.63Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.42Np Likeness Score: -1.67
References 1. Lefranc J, Schulze VK, Hillig RC, Briem H, Prinz F, Mengel A, Heinrich T, Balint J, Rengachari S, Irlbacher H, Stöckigt D, Bömer U, Bader B, Gradl SN, Nising CF, von Nussbaum F, Mumberg D, Panne D, Wengner AM.. (2020) Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor., 63 (2): [PMID:31859507 ] [10.1021/acs.jmedchem.9b01460 ]